Clinical Trials Logo
  1. Home
  2. Retinal Disease
  3. NCT05747430

SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF) — RELIEF  

Retinal Disease Clinical Trial

Official title:
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Epitheliopathy

Clinical Trial Summary

This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 15 centers in the United States (US).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05747430
Study type Interventional
Source iRenix Medical, Inc.
Contact Stephen Smith, MD
Phone 650-785-1316
Email stephen@irenix.com
Status Recruiting
Phase Phase 2
Start date February 22, 2023
Completion date August 30, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04956237 - Retinal Surgery With or Without Anesthesiologist, Comparison of Surgeon and Patient's Comfort
Recruiting NCT01432847 - Cell Collection to Study Eye Diseases
Active, not recruiting NCT04130841 - Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Active, not recruiting NCT03872479 - Single Ascending Dose Study in Participants With LCA10 Phase 1/Phase 2
Active, not recruiting NCT04636307 - Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Completed NCT02315170 - Assessment of Novel Intraocular Injection Guide N/A
Completed NCT00069199 - Optical Coherence Tomography Comparative Study N/A
Withdrawn NCT03603990 - Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema N/A
Active, not recruiting NCT04123626 - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene Phase 1/Phase 2
Withdrawn NCT02445001 - Erythrocyte Ghost Mediated Retinal Diagnosis N/A
Completed NCT01468337 - Topical Interferon Gamma-1b for Central Serous Chorioretinopathy Phase 1/Phase 2
Completed NCT01227993 - Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Phase 1/Phase 2
Completed NCT00792259 - Topcon 3D OCT-1000 Optical Coherence Tomography System
Completed NCT00035906 - Research Study in Patients With Persistent Macular Edema Phase 2
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Terminated NCT04110015 - Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis
Recruiting NCT03592017 - Performance of Long-wavelength Autofluorescence Imaging N/A
Recruiting NCT03823092 - Polarization Perception in Health and Disease. Testing a New Sight Test